tiprankstipranks
Trending News
More News >
NanoViricides (NNVC)
XASE:NNVC
US Market

NanoViricides (NNVC) Income Statement

Compare
601 Followers

NanoViricides Income Statement

Last quarter (Q1 2026), NanoViricides's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, NanoViricides's net income was $-1.79M. See NanoViricides’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ -747.53K$ 0.00$ 0.00
Operating Expenses
$ 9.59M$ 8.52M$ 8.94M$ 8.11M$ 8.74M
Depreciation and Amortization
$ 743.80K$ 759.01K$ 747.53K$ 723.33K$ 704.54K
EBITDA
$ -8.72M$ -7.49M$ -7.84M$ -7.38M$ -8.04M
Operating Income
$ -9.59M$ -8.52M$ -8.94M$ -8.11M$ -8.74M
Other Income/Expenses
$ 124.68K$ 221.97K$ 354.89K$ 6.74K$ -78.08K
Pretax Income
$ -9.47M$ -8.29M$ -8.59M$ -8.11M$ -8.82M
Net Income
$ -9.47M$ -8.29M$ -8.59M$ -8.11M$ -8.82M
Per Share Metrics
Basic EPS
$ -0.63$ -0.70$ -0.74$ -0.70$ -0.81
Diluted EPS
$ -0.63$ -0.70$ -0.74$ -0.70$ -0.81
Weighted Average Shares Outstanding
15.12M 11.87M 11.63M 11.53M 10.90M
Weighted Average Shares Outstanding (Diluted)
15.12M 11.87M 11.63M 11.53M 10.90M
Currency in USD

NanoViricides Earnings and Revenue History